Spots Global Cancer Trial Database for mertk inhibitor
Every month we try and update this database with for mertk inhibitor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL | NCT04872478 | Acute Myeloid L... Acute Lymphobla... Mixed Phenotype... | MRX-2843 | 12 Years - | Meryx, Inc. |